Navigating the EU-U.S. Privacy Shield invalidation for the life sciences and health care industry

5 October 2020

Page d'accueil Évènements Navigating the EU-U.S. Privacy Shield invalidation for the life sciences and health care industry

The validity of personal data transfers to recipients in the United States and non-EU/EEA countries, has been called into question by the Schrems ruling.

Intervenants: Cynthia O'Donoghue

Type d’évènement: Webinar

Date/heure de début: 5 October 2020, 7:00 AM BST
Date/heure de fin: 5 October 2020, 8:30 AM BST

The recent Court of Justice of the European Union (CJEU) decision found the Privacy Shield to be an invalid transfers mechanism to transfer data from the EU to US, and now Switzerland and Israel have following the EU lead and no longer recognize Privacy Shield. The CJEU upheld the use of Standard Contractual Clauses as a , and the SCCs to be valid transfer mechanism, with the latter now subject to additional obligations.

This intimate virtual roundtable which will focus on the impact of this decision on the life sciences and health care industry. Engage in a candid seminar-style discussion with peers across the industry to explore:

Considerations for utilizing SCCs and whether these are still an adequate safeguard for transferring personal data outside the EEA, in particular to the United States
Best practices to navigate transferring data outside of the EEA to the United States and other non-EU countries
What does the future hold for data transfers from the EEA
Potential expectations for the life sciences and health care industry over the course of the next 6-12 months

Cheng, Cue named among top lawyers for DeSPAC transactions

Secteurs

Services

Équipes régionales

PitchBook: Reed Smith leads on PE transactions in healthcare

Ce qui pourrait également vous intéresser

Cheng, Cue named among top lawyers for DeSPAC transactions

PitchBook: Reed Smith leads on PE transactions in healthcare

Partager